The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.
Related Posts
Here’s why Pi coin price could skyrocket soon
The Pi crypto price has plummeted since its mainnet launch in February, turning one of the most popular…
Investors exploring Bonk and this rising crypto in 2024
BONK released the PooperScooper feature while NuggetRush presale gains traction, selling over 159 million NUGX
Coinbase launches perpetual futures trading to non-US retailers
Coinbase has announced the expansion of its perpetual futures trading service to non-US retail clients